Warren Street Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Warren Street Wealth Advisors's VRTX Position: Q2 2026 in Review
Warren Street Wealth Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 9.2% in Q2 2026, buying an estimated $22.6K and bringing the position to 606 shares worth $301K. The position accounts for 0.07% of the portfolio, ranked #104.
Warren Street Wealth Advisors first reported a position in VRTX in Q1 2025 and has held it in 6 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Warren Street Wealth Advisors held 606 shares of Vertex Pharmaceuticals worth $301K as of Q2 2026.
- Warren Street Wealth Advisors bought 51 Vertex Pharmaceuticals shares in Q2 2026, an estimated $22.6K.
- Vertex Pharmaceuticals made up 0.07% of Warren Street Wealth Advisors's portfolio in Q2 2026, its #104 holding.
- Warren Street Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Warren Street Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.